Precigen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Precigen Stock Summary

Precigen competes with CorMedix, Sangamo Therapeutics, Aptose Biosciences, Corvus Pharmaceuticals, and Immutep. Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. Precigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 456 people.

Precigen Key Financial Ratios

Precigen Key Balance Sheet Accounts

Precigen Key Income Statement Accounts

Precigen Key Cash Accounts

Precigen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Precigen's current stock value. Our valuation model uses many indicators to compare Precigen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Precigen competition to find correlations between indicators driving Precigen's intrinsic value. More Info.Precigen is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Precigen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Precigen's earnings, one of the primary drivers of an investment's value.

Precigen Systematic Risk

Today, most investors in Precigen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Precigen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Precigen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Precigen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Precigen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Precigen based on widely used predictive technical indicators. In general, we focus on analyzing Precigen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Precigen's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.